David R. Ebsworth - 01 May 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Reporting relationship: Director
Issuer ticker: VRNA
Reported as of: 01 May 2025
Net transaction value: +$270,732
SEC form: 4
Accepted by SEC: 05 May 2025, 16:30:54 UTC
Prior SEC filing: 29 Apr 2025
Next SEC filing: 05 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Andrew Fisher, Attorney-in-fact for David R. Ebsworth

Key filing fact

David R. Ebsworth filed Form 4 for Verona Pharma plc (VRNA) on 05 May 2025.

Key facts

This page summarizes David R. Ebsworth's Form 4 filing for Verona Pharma plc (VRNA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 May 2025, 16:30.

Change

Previous filing in this sequence was filed on 29 Apr 2025.
Current net transaction value: +$270,732.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001207107 Primary reporting owner

EBSWORTH DAVID R

Relationship: Director
Address: 3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM
Signature: /s/ Andrew Fisher, Attorney-in-fact for David R. Ebsworth
Signature date: 05 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VRNA transaction

Ordinary Shares

Options Exercise

Transaction value: $270,732
Shares: +140,000
Change %: +10%
Price: $1.93
Shares after: 1,476,003
Date: 01 May 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRNA transaction Derivative

Stock Option (Right to Exercise)

Options Exercise

Transaction value: $0
Shares: +140,000
Change %
Price: $0.000000
Shares after: 0
Date: 01 May 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 140,000
Exercise price: $1.93
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.

Footnote F2

Consists of (i) 1,476,000 Ordinary Shares represented by 184,500 ADSs and (ii) 3 Ordinary Shares.

Footnote F3

The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.

Footnote F4

The option is fully vested.